SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from AdaptHealth Corp. (AHCO) (CIK 0001725255) (AHCO) — Feb 13, 2018

AdaptHealth Corp. (AHCO) (CIK 0001725255)
Date: Feb. 13, 2018 · CIK: 0001725255 · Accession: 0001104659-18-009169

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-222376

Date
February 14, 2018
Author
GOLDMAN SACHS & CO. LLC
Form
CORRESP
Company
AdaptHealth Corp. (AHCO) (CIK 0001725255)

Letter

VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Mail Stop 3561 Washington, D.C. 20549 Attention: Laura Nicholson Re: DFB Healthcare Acquisitions Corp. Registration Statement on Form S-1 (File No. 333-222376)

Dear Ms. Nicholson:

In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of DFB Healthcare Acquisitions Corp. that the effective date of the above-referenced Registration Statement be accelerated so that it will be declared effective at 4:00 pm EST on February 15, 2018 or as soon thereafter as practicable.

The following is supplemental information supplied under Rule 418(a)(7) and Rule 460 under the Act:

i. Dates of distribution: February 7, 2018 through the date hereof.

ii. Number of prospectuses distributed: a total of approximately 2100 copies of the preliminary prospectus were distributed to prospective underwriters, institutional investors, dealers and others.

iii. We have complied and will comply, and have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

[Signature page follows]

Sincerely,
GOLDMAN SACHS & CO. LLC

Show Raw Text
CORRESP
1
filename1.htm

Goldman Sachs & Co. LLC

200 West Street, New York New York 10282

Deutsche Bank Securities Inc.

60 Wall Street, New York, New York 10005

February 14, 2018

VIA EDGAR

Securities and Exchange Commission
 Division of Corporation Finance
 100 F Street, N.E.

Mail Stop 3561
 Washington, D.C. 20549

Attention: Laura Nicholson

Re:

DFB   Healthcare Acquisitions Corp.
   Registration Statement on Form S-1 (File No. 333-222376)

Dear Ms. Nicholson:

In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of DFB Healthcare Acquisitions Corp. that the effective date of the above-referenced Registration Statement be accelerated so that it will be declared effective at 4:00 pm EST on February 15, 2018 or as soon thereafter as practicable.

The following is supplemental information supplied under Rule 418(a)(7) and Rule 460 under the Act:

i.                  Dates of distribution: February 7, 2018 through the date hereof.

ii.               Number of prospectuses distributed: a total of approximately 2100 copies of the preliminary prospectus were distributed to prospective underwriters, institutional investors, dealers and others.

iii.            We have complied and will comply, and have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

[Signature page follows]

Sincerely,

GOLDMAN SACHS & CO. LLC

/s/ Elizabeth Word

Name: Elizabeth Word

Title: Managing Director

DEUTSCHE BANK SECURITIES INC.

/s/ Francis Windels

Name:

Francis Windels

Title:

Managing Director

/s/ Jennifer Sheng

Name:

Jennifer Sheng

Title:

Managing Director

[Signature Page to the Underwriters’ Acceleration Request]